TB Alternative Assets Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
|
+$18.5M |
| 2 |
Futu Holdings
FUTU
|
+$7.97M |
| 3 |
KE Holdings
BEKE
|
+$4.69M |
| 4 |
Tencent Music
TME
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$57.1M |
| 2 |
JD.com
JD
|
+$9.56M |
| 3 |
iQIYI
IQ
|
+$2.06M |
| 4 |
API
Agora
API
|
+$1.41M |
| 5 |
New Oriental
EDU
|
+$1.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 49.77% |
| 2 | Communication Services | 13.06% |
| 3 | Healthcare | 7.81% |
| 4 | Technology | 6.15% |
| 5 | Consumer Staples | 5.07% |
Similar funds
TB Alternative Assets's Q4 2021 Portfolio in Review
As of Q4 2021, TB Alternative Assets held 33 positions worth $338M, down 21% from $430M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
TB Alternative Assets withdrew a net $44.2M in Q4 2021, closing 2 positions and reducing 16 holdings. Its most notable exit was Pinduoduo, an estimated $57.1M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 50% of assets, up from 35% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, TB Alternative Assets opened a new position in Pear Therapeutics, Inc. Class A Common Stock worth $12.8M.
- TB Alternative Assets's largest Q4 2021 buy was Pear Therapeutics, Inc. Class A Common Stock: 2,071,865 shares worth $12.8M.
- TB Alternative Assets added most to Futu Holdings in Q4 2021, an estimated $7.97M increase.
- TB Alternative Assets's biggest Q4 2021 reduction was iQIYI, cutting an estimated $2.06M.
- TB Alternative Assets fully exited Pinduoduo in Q4 2021, selling an estimated $57.1M.
- TB Alternative Assets's ten largest holdings make up 82% of its $338M portfolio in Q4 2021.
- TB Alternative Assets opened 1 new position and closed 2 in Q4 2021.
- TB Alternative Assets's portfolio value fell 21% quarter-over-quarter to $338M.
Based on TB Alternative Assets's 13F filing for Q4 2021, filed 18 Jan 2022.